[Divergence of renal sodium and magnesium excretion following administration of trometamol (trisbuffer), amiloroide-HCL, acetazolamide and parathormone -- a result of urinary alkalization?].
D000086:Acetazolamide / Q000008:administration & dosage; D000578:Amidines; D002021:Buffers; D003928:Diabetic Nephropathies / Q000652:urine; D004231:Diuresis / Q000187:drug effects*; D004232:Diuretics / Q000008:administration & dosage*; D005919:Glomerular Filtration Rate; D005921:Glomerulonephritis / Q000652:urine; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007668:Kidney / Q000187:drug effects; D008274:Magnesium / Q000652:urine*; D009318:Natriuresis / Q000187:drug effects*; D010281:Parathyroid Hormone / Q000008:administration & dosage; D011188:Potassium / Q000652:urine; D011704:Pyelonephritis / Q000652:urine; D011719:Pyrazines / Q000008:administration & dosage; D014325:Tromethamine / Q000008:administration & dosage; D014556:Urine
D000578:Amidines; D002021:Buffers; D004232:Diuretics; D010281:Parathyroid Hormone; D011719:Pyrazines; D014325:Tromethamine; D008274:Magnesium; D000086:Acetazolamide; D011188:Potassium
Divergenz der renalen Natrium- und Magnesiumexkretion nach Trometamol (Trispuffer), Amilorid-HCL, Acetqzolamid und Parathormon -- ein Effekt der Harnalkalisierung.